Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20230802047601/en/MyMD-Pharmaceuticals-to-Hold-Conference-Call-Today-to-Discuss-Phase-2-Trial-Results
Aug 2, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next